Cargando…

Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect

Cancer cells adopt glycolysis as the major source of metabolic energy production for fast cell growth. The HIF-1-induced PFKFB3 plays a key role in this adaptation by elevating the concentration of Fru-2,6-BP, the most potent glycolysis stimulator. As this metabolic conversion has been suggested to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Minsuh, Kim, Jeong-Do, Neau, David, Sehgal, Inder, Lee, Yong-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177832/ https://www.ncbi.nlm.nih.gov/pubmed/21957443 http://dx.doi.org/10.1371/journal.pone.0024179

Ejemplares similares

Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer
por: Sha, Liying, et al.
Publicado: (2021)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway
por: Zhao, Shu-Jie, et al.
Publicado: (2018)

PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
por: Zhu, Wei, et al.
Publicado: (2016)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

MicroRNA-3666 Suppresses Cell Growth in Head and Neck Squamous Cell Carcinoma Through Inhibition of PFKFB3-Mediated Warburg Effect
por: Chen, Lan, et al.
Publicado: (2020)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical
por: Kong, Yichao, et al.
Publicado: (2023)

Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
por: Li, Shasha, et al.
Publicado: (2021)

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
por: Mondal, Susmita, et al.
Publicado: (2018)

The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer
por: Lu, Luo, et al.
Publicado: (2017)

The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
por: Emini Veseli, Besa, et al.
Publicado: (2021)

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer
por: Weber, Helga, et al.
Publicado: (2017)

Small molecule KDM4s inhibitors as anti-cancer agents
por: Lin, Hongzhi, et al.
Publicado: (2018)

Autophagy, Warburg, and Warburg Reverse Effects in Human Cancer
por: Gonzalez, Claudio D., et al.
Publicado: (2014)

An Apoptotic and Endosymbiotic Explanation of the Warburg and the Inverse Warburg Hypotheses
por: Kaczanowski, Szymon, et al.
Publicado: (2018)

The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
por: Kornberg, Michael D.
Publicado: (2020)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Covalent Small Molecule Inhibitors of Ca(2+)-Bound S100B
por: Cavalier, Michael C., et al.
Publicado: (2014)

Warburg's Tincture
Publicado: (1885)

Warburg's Tincture
por: Brown, T. E. B.
Publicado: (1876)

Warburg's Tincture
por: Maclean, W. C.
Publicado: (1876)

Warburg’s vision
por: Hurley, James B
Publicado: (2017)

Role of PFKFB3-driven glycolysis in sepsis
por: Xiao, Min, et al.
Publicado: (2023)

Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics
por: Sharma, Chiranjeev, et al.
Publicado: (2018)

Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
por: Qin, Rui, et al.
Publicado: (2022)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
por: Telang, Sucheta, et al.
Publicado: (2014)

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
por: Bechman, Katie, et al.
Publicado: (2019)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2023)

Targeting Cancer Metabolism - Revisiting the Warburg Effects
por: Tran, Quangdon, et al.
Publicado: (2016)

PFKFB3: A Potential Key to Ocular Angiogenesis
por: Zhou, Zi-Yi, et al.
Publicado: (2021)

Functional diversity of PFKFB3 splice variants in glioblastomas
por: Heydasch, Ulli, et al.
Publicado: (2021)

Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism
por: Zhou, Yong, et al.
Publicado: (2022)

Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent
por: Harikishore, Amaravadhi, et al.
Publicado: (2013)

Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies
por: Shetu, Shaila A., et al.
Publicado: (2022)

Walker-Warburg syndrome
por: Vajsar, Jiri, et al.
Publicado: (2006)

Partners in the Warburg effect
por: Rabinowitz, Joshua D, et al.
Publicado: (2016)

Warburg's Tincture Tabloids
Publicado: (1888)

Cannot write session to /tmp/vufind_sessions/sess_kbvfflubikgfrtse4en202cfra